Suyou Liu

Changsha, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Silybin Derivative B1 Inhibits Myofibroblast Activation via Wnt/DAAM2 and Ameliorates Oral Submucous Fibrosis in Mice.

Silybin Derivative B1 Inhibits Myofibroblast Activation via Wnt/DAAM2 and Ameliorates Oral Submucous Fibrosis in Mice.

Journal: International dental journal

Published: March 25, 2026

Discovery of Cdc20/Hsp90 Dual-Target Inhibitors with Potent Antitumor Activity for Therapy of Acquired Resistant Melanoma.

Discovery of Cdc20/Hsp90 Dual-Target Inhibitors with Potent Antitumor Activity for Therapy of Acquired Resistant Melanoma.

Journal: Journal of medicinal chemistry

Published: October 17, 2025

Discovery of a novel napabucasin derivative B16 as a potent STAT3 inhibitor for the treatment of triple-negative breast cancer.

Discovery of a novel napabucasin derivative B16 as a potent STAT3 inhibitor for the treatment of triple-negative breast cancer.

Journal: European journal of medicinal chemistry

Published: August 02, 2025

Discovery of a Novel Silybin Derivative for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis.

Discovery of a Novel Silybin Derivative for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis.

Journal: Journal of medicinal chemistry

Published: June 10, 2025

LM2I leads to CAD ubiquitination and liver cancer suppression through activation of ASS1.

LM2I leads to CAD ubiquitination and liver cancer suppression through activation of ASS1.

Journal: Acta biochimica et biophysica Sinica

Published: May 31, 2025

ASS1 inhibits liver cancer by promoting CAD ubiquitination and reversing the urea cycle and pyrimidine synthesis imbalance.

ASS1 inhibits liver cancer by promoting CAD ubiquitination and reversing the urea cycle and pyrimidine synthesis imbalance.

Journal: Hepatology communications

Published: February 07, 2025

Design, Synthesis, and Biological Activity of Novel Quinone Derivatives as Potent STAT3 Inhibitors for Psoriasis Treatment.

Design, Synthesis, and Biological Activity of Novel Quinone Derivatives as Potent STAT3 Inhibitors for Psoriasis Treatment.

Journal: Journal of medicinal chemistry

Published: August 16, 2024

Exploration of inhibitors targeting KIF18A with ploidy-specific lethality.

Exploration of inhibitors targeting KIF18A with ploidy-specific lethality.

Journal: Drug discovery today

Published: June 03, 2024

Synthesis and biological evaluation of novel isoxazoloquinone derivatives as potent STAT3-targeting antipsoriasis agents.

Synthesis and biological evaluation of novel isoxazoloquinone derivatives as potent STAT3-targeting antipsoriasis agents.

Journal: Bioorganic chemistry

Published: May 08, 2024

Naphthoquinone-derived ZSW-4B induces apoptosis in triple-negative breast cancer via AMPK signalling activation.

Naphthoquinone-derived ZSW-4B induces apoptosis in triple-negative breast cancer via AMPK signalling activation.

Journal: Scientific reports

Published: January 27, 2024

Spinosyn A and Its Derivative Inhibit Colorectal Cancer Cell Growth via the EGFR Pathway.

Spinosyn A and Its Derivative Inhibit Colorectal Cancer Cell Growth via the EGFR Pathway.

Journal: Journal of natural products

Published: September 08, 2023

An Isoxazoloquinone Derivative Inhibits Tumor Growth by Targeting STAT3 and Triggering Its Ubiquitin-Dependent Degradation.

An Isoxazoloquinone Derivative Inhibits Tumor Growth by Targeting STAT3 and Triggering Its Ubiquitin-Dependent Degradation.

Journal: Cancers

Published: March 17, 2023

Showing 1-12 of 15

Last Updated: 09/26/2026